ReviewACS infectious diseases2026
The Future of Protozoan Infection Research: 3D Cell Culture and beyond.
Review in ACS infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protozoan infections remain a major challenge to human health, owing to the substantial impact these parasites exert on their hosts. In vitro culture systems are fundamental for elucidating the host-parasite interactions underlying these infections; however, traditional two-dimensional models are often limited and fail to recapitulate key aspects of human tissue architecture and function. In this context, advanced in vitro cell culture models have emerged as powerful tools, offering increased morphofunctional resemblance to human tissues. This review critically examines recent studies employing advanced platforms, including Transwell systems, spheroids, organoids, scaffolds and biomaterials, microfluidic devices, and organ-on-chip technologies. Collectively, these approaches enable the modeling of diverse human tissues, such as the intestine, brain, heart, and vascular compartments, and support the investigation of multiple pathogenic protozoa, including
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.